Our new study, "Evaluation of real-world tumor response derived from electronic health record data sources," published by @JCOCCI_ASCO and in collaboration with @CancerResrch, is now live! Read the full study: #RWE #RWD #RWEFriends

Good morning from #ASCO24! We're excited to showcase our latest research today: 📌 Assessing secular trends in lung cancer stage in the United States community oncology setting from 2013 to 2023 👩‍🔬 Jessica Paulus 🕘 9 a.m. - 12 p.m. CT 📍 Poster Board #373 #ASCO24 #LungCancer

Just one more full day of ASCO 2024! Don't miss our live poster presentation tomorrow, and be sure to read our three online abstract publications as well. Details below. #ASC024 #CommunityOncology

Welcome to ASCO 2024! Our team is at booth No. 32131, and we'd love to talk to you about how Ontada is transforming the fight against cancer with data, research, and technology. Contact us to connect at ASCO: #ASCO24 #RWD #RWE

Did you know? In addition to Jess Paulus' in-person poster presentation at ASCO 2024, we also have three online publications. Be sure to check them out! #ASCO24 #CommunityOncology

NEXT WEEK: On June 3, Jessica Paulus, ScD Epidemiology, will present our latest research on secular trends in lung cancer stage at ASCO 2024 from 9 a.m. - 12 p.m. CT at poster board #373. If you're attending the event, don't miss it! #ASCO24 #LungCancer #CommunityOncology

Attending ASCO 2024 June 1-3 in Chicago? Stop by @McKesson booth No. 32131 to learn how Ontada’s #RWD and #RWE is helping to advance cancer care. And don’t miss our live poster presentation on Monday, June 3. Contact us to connect at ASCO: #ASCO24

Just a few more days until ASCO 2024! Schedule a time to meet with our team to learn more about how Ontada's #RWD and #RWE are helping advance cancer care:

Mark your calendar! On June 3, Jessica Paulus, ScD Epidemiology, will present our latest research on secular trends in lung cancer stage at ASCO 2024 from 9 a.m. - 12 p.m. CT at poster board #373. #ASCO24 #LungCancer #CommunityOncology

ASCO 2024 is almost here, and our team is excited to talk about how Ontada's #RWD and #RWE are helping advance cancer care. Schedule a time to meet with our team today:

TODAY AT ISPOR 2024: Be sure to visit our two live #RWR poster sessions, presented by Jess Paulus, ScD Epidemiology, and Kat Aguilar, MPH. #ISPORAnnual #RWR

JOIN US TODAY from 11:45 a.m. - 12:15 p.m. ET in the ISPOR 2024 Exhibit Hall Theater for a presentation by Nicholas Robert, MD, Amy O’Sullivan, PhD, and Zhaohui Su, PhD, on rare cancers. #RareCancers #ISPORAnnual

TODAY AT ISPOR 2024: Stop by our live poster session about chart abstraction, presented by Sarah Spark, MHA, MBA, BSN. #ISPORAnnual #RWR

TODAY AT ISPOR 2024: Don’t miss our two live poster sessions featuring our latest real-world research, presented by Zhaohui Su, PhD, and Jess Paulus, ScD Epidemiology. #ISPORAnnual #RWR

Join us May 7 from 11:45 a.m. - 12:15 p.m. ET in the ISPOR 2024 Exhibit Hall Theater for a presentation on rare cancers by Nicholas Robert, MD; Amy O’Sullivan; and Zhaohui Su, PhD. Request a meeting: #RareCancers #ISPORAnnual

Join us at ISPOR 2024 from May 5-8 in Atlanta. We'll be presenting five abstracts live during the conference, and you can also visit us in person at booth No. 1019! Request a meeting today 👇 #ISPORAnnual #RWR

Just a few more days until ISPOR 2024 — be sure to connect with us if you'll be there! Sign up to meet the Ontada team May 5-8 to discuss our real-world data and research offerings. Set up a meeting today 👇 #ISPORAnnual #RWR

Today at #AXS2024: Lyn Fitzgerald joins leaders at @ADVIhealth and @PhRMA for a panel about 2024 election policies impacting #PatientCare. 📌 2024 Election Policy Issues and the Patient Journey Ripple Effect: #IRA, The War on Cancer, and More 🗓️ Tuesday, 4/30 🕐 1-1:40 p.m. PT

Going to ISPOR 2024? Meet the Ontada team May 5-8 in Atlanta! We would love to connect with you to discuss our real-world data and research offerings. Set up a meeting today 👇 #ISPORAnnual #RWR

We're halfway through #AACR2024! Today: 🧬 Examination of VUSs and co-occurring mutations from Comprehensive Genomic Profiling (CGP) Results in a Cross Tumor Model 👨‍🏫 Tincy Simon, PhD 📅 Monday, April 8 🕔 9 a.m. - 12:30 p.m. PT 🔗 #CGP #Genomics